Compassionate Use of REGN-COV2 for the Treatment of COVID-19

NCT04617535 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: REGN10933+REGN10987 combination therapy

Sponsor

Regeneron Pharmaceuticals